Winter is prime time for COPD. You can’t get rid of the disease, but treatment can improve quality of life.Key takeaways:COPD ...

An estimated 30 million Americans are affected by chronic obstructive pulmonary disease (COPD), but surprisingly, only 17 million have received a diagnosis. Texas alone accounts for 1.2 million of ...

Good afternoon, and welcome to the MannKind Corporation third quarter 2024 financial results earnings call. As a reminder, ...

"The hospital has to offer a hospital-at-home program, the patient has to qualify medically by not needing the ICU or a high-tech admission, and the patient needs to have a suitable home with running ...

With the air quality reeling under 'very poor' category in the national capital for several days and the average AQI falling ...

"We have seen approximately a 15 to 20 per cent increase in the number of patients who have come with worsening respiratory problems, patients who have pre-existing asthma, we are seeing a lot more ...

WILMINGTON, Del., November 08, 2024--(BUSINESS WIRE)--Positive high-level results from the Phase III WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps (CRSwNP [nasal polyps]) ...

Exposure to mycobacterium avium complex (MAC) infection happens because of contaminated water or soil. Learn who gets severe ...

Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ETCompany ParticipantsMichael Castagna - CEOChris Prentiss ...

Amgen and AstraZeneca today announced positive top-line results from the Phase 3 WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps (CRSwNP [nasal polyps]). The trial ...